# Once Versus Twice Daily Mesalamine to Induce Remission in Pediatric Ulcerative Colitis

> **NCT01201122** · PHASE4 · COMPLETED · sponsor: **Wolfson Medical Center** · enrollment: 86 (actual)

## Conditions studied

- Mild to Moderate Ulcerative Colitis

## Interventions

- **DRUG:** Mesalamine

## Key facts

- **NCT ID:** NCT01201122
- **Lead sponsor:** Wolfson Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2015-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01201122

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01201122, "Once Versus Twice Daily Mesalamine to Induce Remission in Pediatric Ulcerative Colitis". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01201122. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*